Norstella is a global leader in pharma intelligence solutions, established in 2022, but with a rich legacy that dates back to 1939. The company unites renowned brands such as Citeline, Evaluate, MMIT, Panalgo, and The Dedham Group, each contributing vital insights that enhance strategic decision-making throughout the drug development lifecycle. Norstella focuses on accelerating the drug development process and improving patient access to life-saving therapies by harnessing advanced technologies, including real-world data, machine learning, and predictive analytics. With a robust presence across the USA, UK, The Netherlands, Japan, China, and India, Norstella is dedicated to fostering innovation and collaboration among its global team of experts to tackle complex pharmaceutical challenges effectively.